Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_assertion description "[Interestingly, 90% of patients with advanced stage cancer (stage IIIB/IV NSCLC or extensive SCLC) overexpressed HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_assertion evidence source_evidence_literature NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_assertion SIO_000772 11679181 NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_assertion wasDerivedFrom befree-20150227 NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_assertion wasGeneratedBy ECO_0000203 NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP380541.RAhZj4cl5zBqCimW64ty26UNzu7h1LPpWlCPCpWfmXxPg130_provenance.